Various analytical methods for analysis of atorvastatin: A review

ANALYTICAL METHODS FOR ANALYSIS OF ATORVASTATIN: A REVIEW

  • Pooja A Chawla Indo Soviet Friendship College of Pharmacy, Moga
  • Shailendra Pandey Department of Pharmacy, Sarojini Naidu Medical College, Agra, India
  • , Monika Department of Pharmaceutical Chemistry, Babu Banarasi Das University, Faizabad Road, Lucknow, U.P., India

Abstract

Hyperlipidemia is produced due to abnormal elevated level of lipids in the blood and is a major risk factor for many heart diseases such as atherosclerosis and stroke.  Lipids have been implicated in the development of atherosclerosis in humans. In hyperlipidemia there are increased levels of both LDL and triglycerides. Treatment of hyperlipidemia with statins has become an integral part of management of vascular diseases. Statins are the first line therapy for lowering lipid levels. Among statins atorvastatin is the most effective and currently available antihyperlipidemic drug. An enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase play an important for endogenous cholesterol synthesis. Atorvastatin is HMG-CoA (3-hydroxy-3-methyl-glutaryl-CoA) reductase inhibitor which significantly reduces the lipid levels (low-density lipoprotein, triglycerides, very low-density lipoprotein) and also increases the HDL (high-density lipoprotein) levels. Various analytical methods such as reverse phase high-performance liquid chromatography (RP-HPLC), high performance thin layer chromatography (HPTLC), thin layer chromatography (TLC), ultra-performance liquid chromatography (UPLC), liquid chromatography tendam mass spectroscopy, near infrared spectroscopy, capillary electrophoresis (CE), spectrophotometric methods for determination of atorvastatin as single and in combination with other drugs have been reported.  In this review an attempt has been made to covers all the recent analytical methods which has been used for analysis of atorvastatin.


Keywords: Atorvastatin, Analytical Methods, HPLC, HPTLC.

Downloads

Download data is not yet available.

Author Biography

, Monika, Department of Pharmaceutical Chemistry, Babu Banarasi Das University, Faizabad Road, Lucknow, U.P., India

Department of Pharmaceutical Chemistry, Babu Banarasi Das University, Faizabad Road, Lucknow, U.P., India

References

1. Sweetman S C M. The Complete Drug Reference. The Pharmaceutical Press; 2002, P. 842-43.
2. Hardman JG, Limbird LE, Gillman G. The Pharmacological Basis of Therapeutics. Mc Graw-Hill Medical Publishing Division; 2010. P. 985.
3. Abraham DJ, Burgers Medicinal Chemistry and Drug Discovery. A John Wiley and Sons, Inc. Publication; 2003. P. 13.
4. Barar FSK. Essential of Pharmacotherapeutics. S. Chand & Company Ltd; 2007. P. 346.
5. Maryadele J O H. The Merck Index, Merck Research Laboratories Division of MERCK & Co. INC; 2006. P. 143.
6. Tripathi KD. Essential of Medical Pharmacology. Jaypee Brothers Medical Publishers (P) Ltd; 2008. P. 615.
7. Lemke TL, William s DA, Roche VF, Zito SW. Foyes Principles of Medicinal Chemistry. Lippincott Williams & Wilkins Publication; 2009. P. 809.
8. Rang HP, Dale MM, Ritter TM, Moore PK. Pharmacology. Elsevier Science; 2006. P. 390.
9. Lemke TL, William s DA, Roche VF, Zito SW. Foyes Principles of Medicinal Chemistry. Lippincott Williams & Wilkins Publication; 2009. P. 810.
10. Mycek MJ, Harvey RA Champe PC. Lippincotts Iilustrated Reviews: Pharmacology. Lippincott Williams & Wilkins; 2000. P. 215.
11. Block J H, Beale J M. Wilson & Gisvold  s Textbook of Organic Medicinal and Pharmaceutical Chemistry. Lippincott Williams & Wilkins; 2004. P. 619.
12. Advanced Drug Review (ADR). The Arora Medical Book Publishers Pvt. LTD; 2007. P. 151.
13. Current Index of Medical Specialties. Medimedia Health Private Ltd. Bangalore, India; 2006. P. 306-308.
14. Bangaruthalli J, Harini U, Divya M, Sushma P, Eswar N, Simultaneous estimation of telmisartan and atorvastatin calcium in API and tablet dosage form, Journal of Drug Delivery and Therapeutics, 2019; 9(1):175-179.
15. Chaudhari SM, Karan MP, Luhar SV, Narkhede SB, Rp-hplc method development and validation for simultaneous Estimation of atorvastatin, aspirin, ramipril and metoprolol succinate in tablet dosage form, Pharma science monitor an international journal of pharmaceutical science, 2018; 9 (2): 205-217.
16. Pratiksha D, Rao N, Stability indicating rp-hplc method for estimation of atorvastatin and clopidogrel in pharmaceutical dosage form, Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry, 2018; 6 (1): 6-13.
17. Hassan AA, Ahmed MA, Mohammed AA, Raad K A, Mohammed AB, Zia R, Javed SS, Ismail AA, A fast and validated reversed-phase hplc method for simultaneous determination of simvastatin, atorvastatin, telmisartan and irbesartan in bulk drugs and tablet formulations, Scientia Pharmaceutica, 2018; 86: 1-13.
18. Tomlesh B D, Deo SS, Inam FS, Development and method validation of atorvastatin calcium and telmisartan in tablet dosage form by rp-hplc method, Journal of Pharmaceutical, Chemical and Biological Sciences, 2018; 6(1), 16-24.
19. Yugatama A, Rohmani S, Dewangga, Development and validation of high performance liquid chromatography method for determination atorvastatin in tablet, International Conference on Advanced Materials for Better Future, 2017; 333.
20. Porwal PK, Gokul ST, Development of validated HPLC-UV method for simultaneous determination of metformin, amlodipine, glibenclamide and atorvastatin in human plasma and application to protein binding studies, Bulletin of Faculty of Pharmacy, Cairo University, 2017; 55:129–139.
21. Hassan SA, Elzanfaly ES, Salem MY, El-zeany, BA, Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets, Acta Pharmaceutica, 2016; 66: 479–490.
22. Sangshetti JN, Mohammed A, Zaheer Z, Ahmed RZ, Dehghan MHG, Gonjari I, Development and validation of RP-HPLC method for determination of atorvastatin calcium and nicotinic acid in combined tablet dosage form, Journal of Saudi Chemical Society, 2016, 20, S328–S333.
23. Cansel KO, Ozgur E, Sevinc K, Ayhan S, Ozkan SA, Ozkan Y, Development of a suitable dissolution method for the combined tablet formulation of atorvastatin and ezetimibe by rp-hplc method, Current Drug Delivery, 2016; 13: 1-3.
24. Bkhaitan MM, Mirza AZ, Stability-indicating HPLC-DAD method for simultaneous determination of atorvastatin, irbesartan, and amlodipine in bulk and pharmaceutical preparations, Bulletin of the Korean Chemical Society, 2015; 36: 2230–2237.
25. Kumar SA, Debnath M, Rao SJV, New validated rp-hplc analytical method for simultaneous estimation of atorvastatin and ezetimibe in bulk samples as well in tablet dosage forms by using PDA detector, Current Drug Discovery Technologies, 2014;11(4): 259-70.
26. Kurakula M., Sobahi TR, El-Helw AM, Abdelaa, MY, Development and validation of a rp-hplc method for assay of atorvastatin and its application in dissolution studies on thermosensitive hydrogel-based nanocrystals, Tropical Journal of Pharmaceutical Research, 2014; 13 (10): 1681-1687.
27. Oliveira MA, Yoshida MI, Belinelo VJ, Valotto, RS, Degradation kinetics of atorvastatin under stress conditions and chemical analysis by HPLC, Molecules, 2013; 18: 1447-1456.
28. Suma BV, Kanna K, Madhavan V, Nayar CR, Simultaneous estimation and validation of atorvastatin calcium and aspirin in combined capsule dosage form by rp hplc method, E-Journal of Chemistry, 2012; 9 (3): 1449-1456.
29. Bhinge SD, Malipatil SM, Jondhale A, Hirave R, Savali S, A new approach to the rp-hplc method for simultaneous estimation of atorvastatin calcium and fenofibrate in pharmaceutical dosage forms, E-Journal of Chemistry, 2012; 9(3): 1223-1229.
30. Talluri MVNK, Kalyankar A, Ragampetaa S, Synchronized separation of atorvastatin—an antihyperlipidemic drug with antihypertensive, antidiabetic, antithrombotic drugs by RP-LC for determination in combined formulations, Journal of Pharmaceutical Analysis, 2012; 2(4):285–292.
31. Nagaraju P, Sridhar B, Kumar JP, Rao UU, Rao KH, Gopal PNV, RP-HPLC method for the estimation of atorvastatin calcium in bulk and pharmaceutical formulations, Asian Journal of Research in Chemistry, 2011, 4(3) 434-436.
32. Hirave R, Bendagude R, Kondawar M, RP-HPLC method for simultaneous estimation of atorvatatin calcium and fenofibrate in tablet dosage forms, Journal of Pharmacy Research, 2010, 3 (10), 2400-2401.
33. Jena A, Madhu M, Latha S, Analytical method development and validation of simultaneous determination of atorvastatin calcium and amlodipine besilate in tablet dosage form by RP-HPLC, International Journal of Pharma Sciences and Research, 2010; 1(11): 100-106.
34. Kumar SGV, Rajendraprasad Y, Chandrashekar SM, Development and validation of reversed-phase hplc method for simultaneous estimation of atorvastatin calcium and telmisartan in tablet dosage form, International Journal of Pharm Tech Research, 2010; 2(1): 463-470.
35. Shetty SK, Koduru V S, Pullapanthula R, Borkar RM, Devrukhakar PS, Jogul J, Tripathi UM, Quantitative application to a polypill by the development of stability indicating LC method for the simultaneous estimation of aspirin, atorvastatin, atenolol and losartan potassium, American Journal of Analytical Chemistry, 2010; 2: 59-69.
36. Gupta KR, Askarkar SS, Wadodkar SG, Stability indicating rp-hplc method for simultaneous determination of atorvastatin and nicotinic acid from their combined dosage form. Eurasian Journa lof Analytical Chemistry, 2009; 4(3): 294-303.
37. Zaheer Z, Farooqui MN, Mangle AA, Nikalje AG, Stability-indicating high-performance liquid chromatographic determination of atorvastatin calcium in pharmaceutical dosage form. form. African Journal of Pharmacy and Pharmacology, 2008; 2(10): 204-210.
38. Qutab SS, Razzaq SN, Khan IU, Simultaneous determination of atorvastatin calcium and ezetimibe in pharmaceutical formulations by liquid chromatography, Journal of Food and Drug Analysis, 2007; 15 (2): 139-144.
39. Shah DA, Bhatt KK, Mehta RS, Development and validation of a RP-HPLC method for determination of atorvastatin calcium and nicotinic acid in combined tablet dosage form, Indian Journal of Pharmaceutical Sciences, 2007; 69 (5): 700-703.
40. Shah DA, Bhatt KK, Mehta RS, Shankar MB, Baldania SL, Gandhi TR., Stability indicating rp-hplc estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations, Indian Journal of Pharmaceutical Sciences, 2007; 69: 546-549.
41. Mohammadi A, Rezanour N, Ansari DM, Ghorbani BF, Hashem M, Walker RB, Journal of Chromatography B., 2007; 846: 215-221.
42. Alla K, Stability-Indicating LC method for the simultaneous determination of metoprolol, atorvastatin and ramipril in combined pharmaceutical dosage form. Journal of the Association of official Analytical Chemists International, 2007; 90: 1547-1553.
43. Chaudhari BG, Patel NM, Shah PB, Patel LJ, Patel VP, Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products. Journal of the Association of official Analytical Chemists, 2007; 90 (6): 1539-1546.
44. Raja RK, Sankar GG, Rao AL, Seshagirirao JVLN, RP-HPLC method for the simultaneous determination of atorvastatin and amlodipine in tablet dosage form, Indian Journal of Pharmaceutical Sciences, 2006; 68: 275-277.
45. Stanisz B, Kania L, Validation of hplc method for determination of atorvastatin in tablets and for monitoring stability in solid phase, Acta Poloniae Pharmaceutica and Drug Research, 2006; 63(6): 471-476.
46. Pasha MK, Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Analysis of five HMG-CoA reductase inhibitors- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies, Biomedical Chromatography, 2006; 20: 282-293.
47. Bahrami G, Mohammadi B, Mirzaeei S, Kiani A, Determination of atorvastatin in human serum by reversed-phase high performance liquid chromatography with UV detection, Journal of Chromatography B, 2005, 826, 4145.
48. Manoj K, Shanmugapandiyan P, Anbazhagan S, A RP HPLC method for simultaneous estimation of atorvastatin and aspirin from capsule formulation, Indian Drugs, 2004; 41: 284-288.
49. Erturk S, Aktas ES, Ersoy L, Fccoglu S, An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets, Journal of Pharmaceutical and Biomedical Analysis, 2003; 33: 1017-1023.
50. Bernard S, Rani S, Babitha MC, New spectrophotometric method for the estimation of atorvastatin calcium and aspirin using urea as hydrotropic solubilizing agent, Hygeia. Journal for drugs and medicines, 2018; 9(2): 11-19.
51. Tomlesh B D, Sujata S D, Farhin S I, Simultaneous estimation of atorvastatin calcium and telmisartan in tablet dosage form by spectrophotometry, International journal of pharmacy and pharmaceutical research, 2018; 11(2): 46-58.
52. Alshabrawy A, Mostafa A, Abotaleb N, Sensitive spectrophotometric determination of atorvastatin in pharmaceutical formulation by ion pair complexation with pararosaniline hydrochloride, Journal of advanced pharmacy research, 2017; 1 (4): 193-200.
53. Al-Adl SM, Lobna M A A, Maha AM, Mohamed, Spectrophotometric determination of atorvastatin calcium and rosuvastatin calcium in bulk and dosage form using p-dimethylaminobenzaldehyde, Journal of Applied Pharmacy, 2017; 9: 1-7.
54. Ramadan AA, Mandil H, Sabouni J, Determination of atorvastatin calcium in pure and its pharmaceutical formulations using iodine in acetonitrile by UV-Visible spectrophotometric method. International Journal of Pharmacy and Pharmaceutical Sciences, 2015;7 (9): 427-433.
55. Virani P, Sojitra R, Savaj B, Raj H, Jainv, Simultaneous estimation of irbesartan and atorvastatin by first order derivative spectroscopic method in their synthetic mixture use in hypertension condition, Asian Journal of Pharmacy and Technology, 2015; 5(1): 1-7.
56. Rani NU, Keerthana K, Mitha M, Kumar S, Kotamma K, Kiran TMNU, New spectroscopic method for estimation of atorvastatin tablets using hydrotropic solubilization technique. Asian Journal of Pharmaceutical Analysis, 2015; 5(2):100-104.
57.Naveed S, Simple UV spectrophotometric assay of atorvastatin API formulation and their comparative study, Drug Discovery, Toxicology and Medicine. 2014; 14 (2): 211-16.
58. Ashour S, New kinetic spectrophotometric method for determination of atorvastatin in pure and pharmaceutical dosage forms. Pharmaceutica Analytica Acta, 2013; 4(5): 1-6.
59. Kaliappanlango PS, Kumar S, Validated spectrophotometric methods for the simultaneous determination of telmisartan and atorvastatin in bulk and tablets, Pharmceutical Methods, 2012, 3 (2), 112-116.
60. Hirave R, Bendgude RD, Maniyar MG, Kondawar M S, Patil SB, Spectrophotometric method for simultaneous estimation of atorvastatin calcium & fenofibrate in tablet Dosage Form, International Journal of Drug Development and Research, 2013; 5(1): 38-42.
61. Patel GF, Vekaria NR, Dholakiaya B, Estimation of aspirin and atorvastatin calcium in combined dosage form using derivative spectrophotometric method. International Journal of Pharmaceutical Research, 2010; 2 (1): 62 66.
62. Jani DJ, Ahmed M, Shetty SKA, Sridhar BK, Shah JS, Simultaneous spectrophotometric estimation of atorvastatin calcium and amlodipine besylate in combined tablet dosage form by area under curve method, International Journal Chemical Science, 2010; 8(1):701-710.
63. Kumbhar ST, Jadhav SD, Bhatia NM, Bhatia MS, Development and validation of derivative spectrophotometric method for estimation of atorvastatin calcium and amlodipine besylate in tablet dosage form, International Journal of Pharmacy and Pharmaceutical Sciences, 2011; 3(4): 195-197.
64. Patel CP, Parmar RR, Shah DA, Gadhavi AB, Simultaneous estimation of atorvastatin calcium and aspirin in pharmaceutical dosage form by UV spectrophotometric method, International Journal of Institutional Pharmacy and Life Sciences, 2012; 2(2): 112- 115.
65. Havele OS, Havele SS, Simultaneous determination of atorvastatin calcium and pioglitazone hydrochloride in its multicomponent dosage forms by UV spectrophotometry, International Journal Pharmaceutical Sciences and Research, 2011; 1(2): 75-79.
66. Nakarani NV, Bhatt KK, Patel RD, Bhatt HS, Estimation of atorvastatin calcium and fenofibrate in tablets by derivative spectrophotometry and liquid chromatography. Journal of the Association of official Analytical Chemists International, 2007,90, 700-705.
67. Chaudhari KU, Gaikwad PD, Bankar VH, Pawar SP, Development and validation of UV-Spectrophotometric method for simultaneous estimation of telmisartan and atorvastatin calcium in bulk and tablet dosage form, International Journal of Pharmacy & Technology, 2010; 2 (2): 255-264.
68. Vijayalakshmi R, Magesh AR, Ddhanaraju MD, Simultaneous UV spectrophotometric determination of atorvastatin calcium and telmisartan in tablet dosage form. Oriental Journal of Chemistry, 2010; 26(1): 255-258.
69. Prajapati KP, Bhandari A, Spectroscopic method for estimation of atorvastatin calcium in tablet dosage form. Indo Global Journal of Pharmaceutical Sciences, 2011; 1(4): 294-299.
70. Sasikala M, Pravalika A, Bhaskar VU, Teja PH, Development and validation of UV spectrophotometric method for the simultaneous estimation of atorvastatin calcium and pioglitazone hydrochloride in tablet dosage form by derivative spectroscopic method, International Bulletin of Drug Research, 2013; 3(5): 39-48.
71. Jadhav NR, Kambar RS, Nadaf SJ, Dual wavelength spectrophotometric method for simultaneous estimation of atorvastatin calcium and felodipine from tablet dosage form, Advances in Chemistry, 2014,2,1-6.
72. Ibrahim N, Mohamed R, Ahmed I, Shereen T, Ali I, Simultaneous determination of amlodipine besylate and atorvastatin calcium by using spectrophotometric method with multivariate calibration and hplc method implementing “design of experiment, International Journal of Pharmacy and Pharmaceutical Sciences, 2014; 6(1): 419-425.
73. Jadhav SD, Bhatia MS, Thamake SL, Pishawika SA, Spectrophotometric methods for estimation of atorvastatin calcium form tablet dosage forms, International Journal of PharmTech Research, 2010; 2(3):1948-1953.
74. Patil UP, Gandhi SV, Sengar MR, Rajmane VS, Simultaneous determination of atorvastatin calcium and telmisartan in tablet dosage form by spectrophotometry, A International Journal of Chem Tech Research, 2009;1(4): 970-973.
75. Chaudhari BG, Patel AB, Simultaneous spectrophotometric estimation of atorvastatin calcium and amlodipine besylate in tablet dosage forms, International Journal of Chem Tech Research, 2010; 2(1): 633-639.
76. Bernard S, Mathew M, Senthilkumar KL, Girija KN, Simultaneous estimation of atorvastatin calcium and amlodipine besylate by uv spectrophotometric method using hydrotropic solubilization, Hygeia. Journal for drugs and medicines, 2013; 5 (1): 105-112.
77. Rezk M R, Badr KA, Quantification of amlodipine and atorvastatin in human plasma by UPLC-MS/MS method and its application to a bioequivalence study, Biomedical Chromatography, 2018; 32(7): 4224.
78. Maslanka A, Mariusz S, Anna A, Anna K, Urszula H, Wlodzimierz O, Simultaneous determination of acetylsalicylic acid, hydrochlorothiazide, enalapril, and atorvastatin in a polypill-based quaternary mixture by TLC, Journal of the Association of official Analytical Chemists International, 2018; 101(3): 708-713.
79. Szentmiklosi BS, Hancu1G, Szentmiklosi IS, Kovacs B, Kelemen H, Simultaneous determination of atorvastatin and ezetimibe from combined pharmaceutical products by micellar electro kinetic capillary chromatography, Brazilian Journal of Pharmaceutical Sciences, 2017; 53(1): 161-22.
80. Danafar H, Hamidi, Method validation of amlodipine and atorvastatin by liquid chromatography–mass spectrometry (LC–MS) method in human plasma, Cogent Medicine, 2016, 3, 1-11.
81. Yang Y, Xu Q, Zhou L, Zhong D. and Chen X, High throughput salting out assisted liquid–liquid extraction for the simultaneous determination of atorvastatin, ortho-hydroxyatorvastatin, and para‐hydroxyatorvastatin in human plasma using ultrafast liquid chromatography with tandem mass spectrometry, Journal of Separation Sciences, 2015; 38 (6), 1026-1034.
82. Gligor VAL, Reznek TCA, Tomuta I, Gligor F, Direct and simultaneous quantification of atorvastatin and amlodipine in tablets by NIR Spectroscopy, Studia Universitatis Babes Bolyai, Seria Chemia, LX, 2015; 2: 281-293.
83.Jadhav DH Ramaa CS, Development and validation of a simple, sensitive, and rapid method for simultaneous estimation of atorvastatin and its active metabolites in human plasma by LC-ESI-MS/MS, International Journal of Analytical and Bioanalytical Chemistry, 2014, 4(1): 20-2.
84. Ramadan AA, Akraa HA, Mohammad, TLCsimultaneous determination of amlodipine, atorvastatin, rosuvastatin and valsartan in pure form and in tablets using phenyl-modified aleppo bentonite, International Journal of Pharmacy and Pharmaceutical Sciences, 2014; 6(3): 201-23.
85. Baghdady YZ, Al-Ghobashy MA, Abdel AE, Aleem A, Weshahy SA, Spectrophotometric and TLC-densitometric methods for the simultaneous determination of ezetimibe and atorvastatin calcium, Journal of Advanced Research, 2013; 4: 51–59.
86. Gajula R, Pilli N, Vasu BR, Maddela R, Inamadugu JK, Polagani SR, Busa S, Simultaneous determination of atorvastatin and aspirin in human plasma by lc–ms/ms: its pharmacokinetic application, Scientia Pharmarmaceutica, 2012; 80(4): 923–940.
87. Vora DN, Kadav AA, Validated ultra HPLC method for the simultaneous determination of atorvastatin, aspirin, and their degradation products in capsules, Journal of Liquid Chrmatography & Related Technology, 2008; 31(18): 2821-2837.
88. Kadav AA, Vora DN, Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets, Journal of Pharmaceutical and Biomedical Analysis, 2008; 48: 120-126.
89. Jamshidi A, Nateghi AR, HPTLC determination of atorvastatin in plasma, Chromatographia, 2007; 65: 763-766.
90. Chaudhri BG, Patel NM, Shah PB, Modi KP, HPTLC method for the simultaneous estimation of atorvastatin calcium and ezetimibe, Indian Journal of Pharmceutical Sciences., 2006; 68: 793-796.
91. Yadav SS, Mhaske DV, Kakad AB, Patil BD, Kadam SS, Dhaneshwar SR, HPTLC method for the determination of content uniformity of atorvastatin calcium tablets, Indian Journal of Pharmceutical Sciences, 2005; 67: 182-186.
92. Farahani H, Norouzi P, Beheshti A, Sobhi HR, Dinarvand R, Ganjali MR, Quantitation of atorvastatin in human plasma using directly suspended acceptor droplet in liquid-liquid-liquid microextraction and high-performance liquid chromatography-ultraviolet detection, Talanta, 2009; 80: 1001–6.
93. Ashour S, Bahbouh M, Khateeb M, Novel use of oxidative coupling reactions for determination of some statins (cholesterol-lowering drugs) in pharmaceutical formulations. Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy, 2011; 78(3): 913-7. 94.Al-Shehri MM, A validated capillary electrophoresis method for simultaneous determination of ezetimibe and atorvastatin in pharmaceutical formulations, Saudi Pharmaceutical Journal, 2012; 20(2): 143-148.
95. Alghamdi A F, High sensitivity determination of atorvastatin calcium in pharmaceuticals and biological fluids using adsorptive anodic stripping voltammetry onto surface of ultra-trace graphite electrode. Current Analytical Chemistry, 2018; 14 (2): 92-100.
96. Gajula R, Pilli NR, Vasu BR, Maddela R, Kumar IJ, Polagani SR, Busa S, Simultaneous determination of atorvastatin and aspirin in human plasma by LC–MS/MS: its pharmacokinetic application, Scientia Pharmarmaceutica, 2012; 80(4): 923–940.
97. Soni H, Kothari C, Khatri D, Mehta P, Simultaneous determination of atorvastatin calcium and olmesartan medoxomil in a pharmaceutical formulation by reversed phase high-performance liquid chromatography, high-performance thin-layer chromatography, and UV spectrophotometric methods. Journal of the Association of official Analytical Chemists International, 2014; 97(3): 791-7.
98. El-Bagary RI, Elkady EF, El-Sherif ZA, Kadry AM, LC-MS-MS simultaneous determination of atorvastatin and ezetimibe in human plasma, Journal of Chromatographic Sciences, 2014; 52(8):773-80.
99. Sakac MC, Vujcic Z, Markovic B, Vasiljevic D, LC–MS/MS Method for quantification of Atorvastatin, o-Hydroxyatorvastatin, p-Hydroxyatorvastatin, and Atorvastatin Lactone in rat plasma. Acta Chromatographica, 2016; 28(3): 281–298.
100. Rakibe U, Tiwari R, Rane V, Wakte P, UPLC, HR-MS, and in-silico tools for simultaneous separation, characterization, and in-silico toxicity prediction of degradation products of Atorvastatin and Olmesartan, Acta Chromatographica, 2017; 1-12.
101. Liyun C, Zheng Z, Wang X, Tang L, Mai L, Guodong H, Heping L, Zhong S, Simultaneous determination of atorvastatin and its metabolites in human plasma by UPLC-MS/MS, Analytical Methods, 2017; 6(6):201-211.
102. Panchal HJ, Suhagia BN, Simultaneous determination of atorvastatin calcium and ramipril in capsule dosage forms by high-performance liquid chromatography and high-performance thin layer chromatography, Journal of the Association of official Analytical Chemists International, 2010; 93(5): 1450-7.
Statistics
37 Views | 90 Downloads
How to Cite
Chawla, P., Pandey, S., & Monika, ,. (2019). Various analytical methods for analysis of atorvastatin: A review. Journal of Drug Delivery and Therapeutics, 9(3-s), 885-899. https://doi.org/10.22270/jddt.v9i3-s.3004